Single Versus Repeat Betamethasone in Twin Pregnancies
Repeat Versus Single Course of Betamethasone in Twin Pregnancies
1 other identifier
observational
2,000
1 country
1
Brief Summary
Thus far no robust data exist as to the effect of repeted course of antenatal corticosteroids in twin pregnancies. The investigators hypothesized that repeat course of betamethasone would further reduce neonatal morbidity in twins born before 34 weeks' gestation when compared with single dose.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2019
CompletedFirst Posted
Study publicly available on registry
December 26, 2019
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2021
CompletedDecember 26, 2019
December 1, 2019
10 months
November 2, 2019
December 24, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence of respiratory morbidity after single versus repeat course of betamethasone for threatened preterm labor between 24-34 weeks' gestation
The incidence of respiratory morbidity after single versus repeat course of betamethasone for threatened preterm labor between 24-34 weeks' gestation
1 year
Study Arms (2)
Single course of Betamethasone
Women with twin pregnancy who received 1 course of betamethasone between 24 - 34 weeks' gestation.
Repeat course of Betamethasone
Women with twin pregnancy who received 2 courses (Repeat course) of betamethasone between 24 - 34 weeks' gestation.
Eligibility Criteria
Pregnant women carrying twins, and who received antenatal Betamethasone between 24-34 weeks' gestation for threatened preterm labor.
You may qualify if:
- Study group - women who received 2 courses of betamethasone between 24 - 34 weeks' gestation.
- Control comparison group - women who received 1 course of betamethasone between 24 - 34 weeks' gestation.
You may not qualify if:
- singletone pregnancies
- higher order multiple pregnancies (triplets and above)
- known major congenital anomaly
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rambam health care campus
Haifa, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yaniv Zipori, M.D
Rambam Health Care Campus
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 2, 2019
First Posted
December 26, 2019
Study Start
February 1, 2020
Primary Completion
December 1, 2020
Study Completion
January 1, 2021
Last Updated
December 26, 2019
Record last verified: 2019-12